Skip to main content
Caplight Logo









Curie.Bio

Curie.Bio

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://www.curie.bio

Last Round

Seed

Jan 29, 2025

Total Funding Raised

$862.1M

Company Overview

Curie.Bio is a biotechnology company that operates an accelerator to enhance the creation of viable therapeutics firms by assisting founders in securing financing and navigating the drug development process.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Non-AI

Keywords

biotech acceleratorventure studiobiotech venture capitalseed fundingdrug discoverytherapeutics acceleratorventure creationbiotech startupspre-series A fundingdrug development supportdrug discovery co-pilotingbiotech incubatorCRO managementequity for servicescontract research organization

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Curie.Bio Comparables

Compare Curie.Bio with similar companies based on industry and business-model similarity.

No public comparables are available for Curie.Bio. Request access to learn about comparables coverage.

Request access

Curie.Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 29, 2025
VC RoundJun 26, 2024
SeedFeb 14, 2023

Curie.Bio Investors

Notable investors and investment history

Curie.Bio investors
InvestorRounds
Andreessen HorowitzSeed
GVSeed
5AM VenturesSeed
ARCH Venture PartnersSeed
Casdin CapitalSeed
Leaps by BayerSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 14, 2023

    $520M round led by GV

Curie.Bio Filings

Explore SEC and related filing metadata, where available.

Curie.Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Curie.Bio's valuation, stock price, and market status.

Is Curie.Bio a public or private company?

Curie.Bio is a private company.

What is the current stock price of Curie.Bio?

Curie.Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Curie.Bio worth (valuation)?

Valuation information for Curie.Bio is not publicly available.

Can I buy Curie.Bio stock?

Curie.Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Curie.Bio's last funding round?

Curie.Bio's most recent funding round was Seed on January 29, 2025.

Who are the main investors in Curie.Bio?

Key investors in Curie.Bio include GV.

Will Curie.Bio IPO soon?

No public IPO plans have been announced for Curie.Bio.

How can I track Curie.Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Curie.Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range118
Year Founded2022
Last FundingJan 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?